Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis
- PMID: 38347369
- DOI: 10.1007/s10620-023-08260-1
Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis
Abstract
Background: There are two sub-phenotypes of large-duct primary sclerosing cholangitis (PSC): isolated intrahepatic PSC (IIPSC) and extrahepatic disease with or without intrahepatic (extra/intrahepatic).
Aims: This study examined the differences in outcomes in patients with IIPSC compared to extra/intrahepatic and small-duct PSC.
Methods: Patients with PSC treated at our institution from 1998 to 2019 were investigated. Biochemistries, clinical events, and survival were assessed by chart review and National Death Index. Cox-proportional hazards were used to determine the risk of clinical outcomes based on biliary tract involvement.
Results: Our cohort comprised 442 patients with large-duct PSC (57 had IIPSC, 385 had extra/intrahepatic PSC) and 23 with small-duct PSC. Median follow-up in the IIPSC group was not significantly different from the extra/intrahepatic group [7 vs. 6 years, P = 0.06]. Except for lower age (mean 37.9 vs. 43.0 years, P = 0.045), the IIPSC group was not different from the extra/intrahepatic. The IIPSC group had longer transplant-free survival (log-rank P = 0.001) with a significantly lower risk for liver transplantation (12% vs. 34%, P < 0.001). The IIPSC group had a lower risk of death or transplantation than the extra/intrahepatic PSC group [HR: 0.34, 95% CI: 0.17-0.67, P < 0.001]. No bile duct or gallbladder cancers developed in patients with IIPSC, compared to 24 in the extra/intrahepatic group. The clinical characteristics and outcomes of IIPSC were similar to 23 individuals with small-duct PSC.
Conclusions: Patients with IIPSC have a favorable prognosis similar to small-duct PSC. These data are important for counseling patients and designing therapeutic trials for PSC.
Keywords: Cholangiocarcinoma; Cholangitis; Endoscopic retrograde cholangiopancreatography; Extrahepatic; Intrahepatic; Large-duct; Small-duct.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.Am J Surg Pathol. 2007 Jun;31(6):907-13. doi: 10.1097/01.pas.0000213435.99492.8a. Am J Surg Pathol. 2007. PMID: 17527079
-
Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.J Hepatol. 2023 Mar;78(3):604-613. doi: 10.1016/j.jhep.2022.11.011. Epub 2022 Nov 19. J Hepatol. 2023. PMID: 36410555
-
Management of primary sclerosing cholangitis.Minerva Gastroenterol Dietol. 2009 Jun;55(2):163-72. Minerva Gastroenterol Dietol. 2009. PMID: 19305376 Review.
-
Small-duct primary sclerosing cholangitis.Curr Gastroenterol Rep. 2009 Feb;11(1):37-41. doi: 10.1007/s11894-009-0006-6. Curr Gastroenterol Rep. 2009. PMID: 19166657
-
[Primary sclerosing cholangitis : Current diagnostics and treatment].Internist (Berl). 2018 Jun;59(6):551-559. doi: 10.1007/s00108-018-0428-z. Internist (Berl). 2018. PMID: 29700559 Review. German.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical